FDA recall record

Rompe Pecho Ex Expectorant recall — FDA D-0292-2022

Microbial Contamination of Non-Sterile Products

Class IIclassification
D-0292-2022official record ID
Dec 29, 2021report date

Recall record at a glance

Official recordD-0292-2022
CategoryDrug Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmEfficient Laboratories, Inc.
Report dateDec 29, 2021
Recall initiation dateAug 24, 2021
Quantitya) 7,800 bottles; b) 16,417 bottles
LocationMiami, FL, United States

Official product description

Rompe Pecho Ex Expectorant, packaged in a) 4 Fl. Oz. (118 mL) bottles NDC 58593-829-04 and b) 6 Fl. Oz. (178 mL) bottles NDC 58593-829-06, Distributed by Efficient Laboratories, Inc. Miami, FL 33166

Why the product was recalled

Microbial Contamination of Non-Sterile Products

Distribution information

Nationwide within the United States

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.